about
Zagreb regimen, an abbreviated intramuscular schedule for rabies vaccinationThe weight of obesity on the human immune response to vaccinationSero-prevalence of virus neutralizing antibodies for rabies in different groups of dogs following vaccination.First human rabies case in French Guiana, 2008: epidemiological investigation and control.Making rabies prophylaxis more economical: immunogenicity and safety results from a preliminary study using a 2-1 intramuscular regimen in healthy volunteersTranscutaneous vaccination via laser microporation.Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.Laboratory surveillance of rabies in humans, domestic animals, and bats in madagascar from 2005 to 2010.Risk for rabies importation from North Africa.Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG.Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.Validation of the rapid fluorescent focus inhibition test for rabies virus-neutralizing antibodies in clinical samples.Monkey bites among US military members, Afghanistan, 2011.Intradermal vaccination for infants and children.Surveillance and control of rabies in La Reunion, Mayotte, and Madagascar.Safety comparison of four types of rabies vaccines in patients with WHO category II animal exposure: An observation based on different age groupsDevelopment of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system.Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets.Vaccine-preventable travel health risks: what is the evidence--what are the gaps?Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections.Improper wound treatment and delay of rabies post-exposure prophylaxis of animal bite victims in China: Prevalence and determinants.Post-exposure rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2012-2015 - A retrospective study.Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above.APRIL:TACI axis is dispensable for the immune response to rabies vaccination.Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.Rabies Vaccine and Rabies Immunoglobulin in Cambodia: Use and Obstacles to Use.Single visit rabies pre-exposure priming induces a robust anamnestic antibody response after simulated post-exposure vaccination: results of a dose-finding study.Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations.Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children.Global epidemiology of canine rabies: past, present, and future prospectsProtection Against CNS-Targeted Rabies Virus Infection is Dependent upon Type-1 Immune Mechanisms Induced by Live-Attenuated Rabies VaccinesThe evaluation of Animal Bite Treatment Centers in the Philippines from a patient perspective
P2860
Q27023164-0F944EB9-A75F-4834-968E-BB9A46C8B700Q28088540-81CC37C2-24CF-40A8-9C65-4ABD243F2731Q33706236-EEAC84F6-0B8B-4905-B06E-F5CA197A118DQ34171796-D56713F4-15B3-4DB9-8E99-E566B4FA4BD2Q34271459-8C49E26D-D378-49F1-B302-E8D9707FBFACQ34323166-B79B06FA-26B1-4817-B249-6329361EF23BQ34593082-812A0156-E7FC-4FE6-B245-A3CC1005172EQ35207511-110FDD50-F737-40EB-B99E-2F696D21A164Q35849116-955D4244-8B62-434A-8383-F277EA377650Q35886459-4E286DCE-384E-4DA2-9308-8BA2FB3A75F1Q35887112-DF657057-BF51-4DB1-8E18-06816012B4B2Q36086472-3D38D152-482F-44CD-9515-9DCC648EDA5AQ36318479-3F966342-8A06-4D52-8E17-149424C848ACQ37264939-2B8135E8-EF29-4A3C-93EF-47458AE9BF4AQ37360352-AAA5B2EC-152A-442C-9081-7D66D4C945F7Q37468068-AF453BD9-7D96-445C-84D2-D337D474EF9CQ37652192-9BA0AE25-8B07-4BFA-9D9E-CDC53D92F9C4Q38096489-12A6478C-5460-4D46-AAB9-FC0EEE3E8999Q38265969-1BB32C42-8781-4035-ADE3-10DD43C98B5CQ38641485-B536CF2E-CAA5-4187-80E0-C27AA2241058Q38686310-DFF85C92-44C2-4036-B74A-3DF127D102CBQ38760845-6C3476C2-86CB-423B-9C73-B095825EC491Q39043124-501389B1-D3E0-4329-99B3-E681F259B3FDQ40158110-F91C34AD-901C-41CA-BD1F-AB41B774309FQ40355293-82D4FC93-F43B-485F-9E74-4CAD2FD63F72Q41588040-3366658D-A393-4548-B281-9EBB26836783Q41933630-2596D2B7-CB1B-4F4A-996E-59D560F4B55BQ47822365-9EB05ABF-4325-4059-ACD1-283BFC3BB128Q49502107-B75C34D8-9C26-439B-8940-DE8317FB6598Q56765347-D621C1E9-C0A6-446B-B799-E70C96BADBB2Q57152975-D0D9A98B-6DB4-48A4-905E-02BE69A92EA3Q58992847-D81795F6-1EF1-46A2-B48A-D123DF017AD1
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Rabies vaccines: WHO position paper--recommendations.
@en
Rabies vaccines: WHO position paper--recommendations.
@nl
type
label
Rabies vaccines: WHO position paper--recommendations.
@en
Rabies vaccines: WHO position paper--recommendations.
@nl
prefLabel
Rabies vaccines: WHO position paper--recommendations.
@en
Rabies vaccines: WHO position paper--recommendations.
@nl
P1433
P1476
Rabies vaccines: WHO position paper--recommendations.
@en
P2093
WHO Publication
P304
P356
10.1016/J.VACCINE.2010.08.082
P407
P577
2010-09-08T00:00:00Z